Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amand F Schmidt

Showing results (21-30 of 60) with videos related to

Pageof 6
Sort By:
Journal of Clinical Epidemiology|January 3, 2015
Bayesian methods including nonrandomized study data increased the efficiency of postlaunch RCTsAmand F Schmidt, Irene Klugkist, Olaf H Klungel, et al.
JAMA Cardiology|August 3, 2022
Joint Genetic Inhibition of PCSK9 and CETP and the Association With Coronary Artery Disease: A Factorial Mendelian Randomization StudyArjen J Cupido, Laurens F Reeskamp, Aroon D Hingorani, et al.
Frontiers in Cardiovascular Medicine|November 3, 2023
Unraveling the relationships between alpha- and beta-adrenergic modulation and the risk of heart failureClaire Baudier, Françoise Fougerousse, Folkert W Asselbergs, et al.
Human Molecular Genetics|March 29, 2020
Polygenic risk scores for coronary artery disease and subsequent event risk amongst established casesLaurence J Howe, Frank Dudbridge, Amand F Schmidt, et al.
The Cochrane Database of Systematic Reviews|October 20, 2020
PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular diseaseAmand F Schmidt, John-Paul L Carter, Lucy S Pearce, et al.
Atherosclerosis|November 14, 2021
Assessment of practical applicability and clinical relevance of a commonly used LDL-C polygenic score in patients with severe hypercholesterolemiaTycho R Tromp, Arjen J Cupido, Laurens F Reeskamp, et al.
Journal of Clinical Epidemiology|March 21, 2013
Differences in interaction and subgroup-specific effects were observed between randomized and nonrandomized studies in three empirical examplesAmand F Schmidt, Maroeska M Rovers, Olaf H Klungel, et al.
Neurology|September 1, 2023
Exploring the Role of Plasma Lipids and Statin Interventions on Multiple Sclerosis Risk and Severity: A Mendelian Randomization StudyMona M Almramhi, Chris Finan, Catherine S Storm, et al.
Journal of Clinical Epidemiology|April 29, 2014
Exploring interaction effects in small samples increases rates of false-positive and false-negative findings: results from a systematic review and simulation studyAmand F Schmidt, Rolf H H Groenwold, Mirjam J Knol, et al.
Translational Psychiatry|June 2, 2026
An integrative mendelian randomisation and drug mechanism framework for target prioritisation and therapeutic repurposing in major depressionAbigail R Ter Kuile, Chris Finan, Sandesh Chopade, et al.
Pageof 6

Showing results (21-30 of 60) with videos related to

Sort By:
Pageof 6
Journal of Clinical Epidemiology|January 3, 2015
Bayesian methods including nonrandomized study data increased the efficiency of postlaunch RCTsAmand F Schmidt, Irene Klugkist, Olaf H Klungel, et al.
JAMA Cardiology|August 3, 2022
Joint Genetic Inhibition of PCSK9 and CETP and the Association With Coronary Artery Disease: A Factorial Mendelian Randomization StudyArjen J Cupido, Laurens F Reeskamp, Aroon D Hingorani, et al.
Frontiers in Cardiovascular Medicine|November 3, 2023
Unraveling the relationships between alpha- and beta-adrenergic modulation and the risk of heart failureClaire Baudier, Françoise Fougerousse, Folkert W Asselbergs, et al.
Human Molecular Genetics|March 29, 2020
Polygenic risk scores for coronary artery disease and subsequent event risk amongst established casesLaurence J Howe, Frank Dudbridge, Amand F Schmidt, et al.
The Cochrane Database of Systematic Reviews|October 20, 2020
PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular diseaseAmand F Schmidt, John-Paul L Carter, Lucy S Pearce, et al.
Atherosclerosis|November 14, 2021
Assessment of practical applicability and clinical relevance of a commonly used LDL-C polygenic score in patients with severe hypercholesterolemiaTycho R Tromp, Arjen J Cupido, Laurens F Reeskamp, et al.
Journal of Clinical Epidemiology|March 21, 2013
Differences in interaction and subgroup-specific effects were observed between randomized and nonrandomized studies in three empirical examplesAmand F Schmidt, Maroeska M Rovers, Olaf H Klungel, et al.
Neurology|September 1, 2023
Exploring the Role of Plasma Lipids and Statin Interventions on Multiple Sclerosis Risk and Severity: A Mendelian Randomization StudyMona M Almramhi, Chris Finan, Catherine S Storm, et al.
Journal of Clinical Epidemiology|April 29, 2014
Exploring interaction effects in small samples increases rates of false-positive and false-negative findings: results from a systematic review and simulation studyAmand F Schmidt, Rolf H H Groenwold, Mirjam J Knol, et al.
Translational Psychiatry|June 2, 2026
An integrative mendelian randomisation and drug mechanism framework for target prioritisation and therapeutic repurposing in major depressionAbigail R Ter Kuile, Chris Finan, Sandesh Chopade, et al.
Pageof 6